SoFi stock today: SOFI barely moves after Fed minutes; what investors watch next

SoFi stock today: SOFI barely moves after Fed minutes; what investors watch next

NEW YORK, December 30, 2025, 3:01 PM ET — Regular session

  • SoFi shares were down less than 0.1% in afternoon trading, holding in a tight range.
  • The Fed released minutes from its December meeting at 2:00 p.m. ET, keeping rate expectations in focus.
  • Fintech-lender peers were mixed, with Upstart down while Affirm was higher.

SoFi Technologies, Inc. shares were down 0.1% at $26.80 on Tuesday afternoon, after trading between $26.65 and $27.14.

The Federal Reserve released minutes from its Dec. 9–10 meeting at 2:00 p.m. ET, putting fresh attention on how quickly policymakers might cut interest rates again.

That matters for SoFi because investors tend to treat the fintech lender as sensitive to shifts in borrowing costs, which can influence consumer demand for loans and a lender’s funding expenses.

Trading across Wall Street was choppy in a holiday-shortened week, with investors rebalancing exposures late in the year. “It absolutely is justified to see repositioning,” said Mark Hackett, chief market strategist at Nationwide. Reuters

The Fed minutes showed officials were deeply divided over the December quarter-point cut that lowered the benchmark rate to 3.5%–3.75%, with some participants arguing rates should remain unchanged “for some time” after that move. The minutes also flagged a catch-up in key U.S. data, with December jobs and consumer price reports due Jan. 9 and Jan. 13, ahead of the Fed’s next meeting on Jan. 27–28. Reuters

Fintech-lender peers traded unevenly on Tuesday: Affirm was up 0.9%, while Upstart fell 2.7% and LendingClub slipped 0.6%.

SoFi, which operates a consumer financial app alongside a lending business and a technology platform sold to other financial firms, has drawn investors looking for exposure to digital finance and consumer credit trends.

The company’s most recent earnings update came on Oct. 28, when it raised its 2025 profit forecast after record third-quarter results, helped by a jump in fee-based revenue, Reuters reported.

Earlier this month, SoFi sold 54.5 million shares at $27.50 apiece in a public offering, saying it planned to use the proceeds for general corporate purposes including enhancing its capital position and funding growth opportunities.

With rates now closer to what the Fed describes as a “neutral” level, investors are watching whether SoFi can keep growing without a deterioration in credit, particularly if the labor market cools.

Traders also focus on net interest margin — the spread between what a lender earns on loans and pays on funding such as deposits — as the outlook for policy rates shifts.

The next clear company catalyst is fourth-quarter results. Wall Street Horizon lists an unconfirmed earnings date of Jan. 26, before the market open, keeping attention on calendars rather than company guidance for now.

Until then, investors are likely to take their cues from the early-January jobs and inflation reports and the Fed’s late-January meeting, with year-end liquidity still thin and price moves prone to quick reversals.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Taiwan Semiconductor

NYSE: TSM 96 / 100
#2 BUY

AerCap

NYSE: AER 95 / 100
#3 BUY ON PULLBACK

Constellation Energy

NASDAQ: CEG 93 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

American International Group

NYSE: AIG 87 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug
Previous Story

Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

Nebius stock slips today after CEO files to sell shares — what traders are watching next
Next Story

Nebius stock slips today after CEO files to sell shares — what traders are watching next